Cargando…

Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience

BACKGROUND: Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. To date, omalizumab is the only biological drug currently licensed as add-on therapy in children aged > 6 years with moderate-to-severe and severe allergic asthma uncontrolled a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Licari, Amelia, Castagnoli, Riccardo, Denicolò, Chiara, Rossini, Linda, Seminara, Manuela, Sacchi, Lucia, Testa, Giorgia, De Amici, Mara, Marseglia, Gian Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684803/ https://www.ncbi.nlm.nih.gov/pubmed/29213221 http://dx.doi.org/10.2174/1573398X13666170426094536

Ejemplares similares

Omalizumab in Children
por: Licari, Amelia, et al.
Publicado: (2014)

The Nose and the Lung: United Airway Disease?
por: Licari, Amelia, et al.
Publicado: (2017)

Omalizumab may protect allergic patients against COVID-19: A systematic review
por: Ghiglioni, Daniele Giovanni, et al.
Publicado: (2023)

Resilience is low in adolescents with asthma and independent of asthma control
por: Marseglia, Gian Luigi, et al.
Publicado: (2022)

Asthma control in adolescents: the importance of assessing adherence
por: Ciprandi, Giorgio, et al.
Publicado: (2022)

Asthma Endotyping and Biomarkers in Childhood Asthma
por: Licari, Amelia, et al.
Publicado: (2018)

New approaches in childhood asthma treatment
por: Castagnoli, Riccardo, et al.
Publicado: (2023)

Immunomodulation in Pediatric Asthma
por: Licari, Amelia, et al.
Publicado: (2019)

Association between treatment awareness and uncontrolled asthma in adolescents
por: Castagnoli, Riccardo, et al.
Publicado: (2022)

Measuring inflammation in paediatric severe asthma: biomarkers in clinical practice
por: Licari, Amelia, et al.
Publicado: (2020)

Biological Therapies in Children and Adolescents with Severe Uncontrolled Asthma: A Practical Review
por: Votto, Martina, et al.
Publicado: (2021)

Eosinophilic esophagitis after congenital diaphragmatic hernia
por: Licari, Amelia, et al.
Publicado: (2016)

Anxiety and depression in adolescents with asthma: a study in clinical practice
por: Licari, Amelia, et al.
Publicado: (2022)

Pediatric Anaphylaxis: A 20-Year Retrospective Analysis
por: De Filippo, Maria, et al.
Publicado: (2022)

An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases
por: Licari, Amelia, et al.
Publicado: (2017)

Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
por: Manti, Sara, et al.
Publicado: (2021)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Malnutrition in Eosinophilic Gastrointestinal Disorders
por: Votto, Martina, et al.
Publicado: (2020)

Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps
por: Bagnasco, Diego, et al.
Publicado: (2022)

An asymptomatic mediastinal cyst in a young child: Case report and summary of the literature
por: Votto, Martina, et al.
Publicado: (2020)

Management of asthma exacerbations in the paediatric population: a systematic review
por: Manti, Sara, et al.
Publicado: (2021)

Non-invasive biomarkers of eosinophilic esophagitis
por: Votto, Martina, et al.
Publicado: (2021)

Food Allergies: Current and Future Treatments
por: Licari, Amelia, et al.
Publicado: (2019)

Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications
por: Bossi, Grazia, et al.
Publicado: (2023)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Omalizumab: the evidence for its place in the treatment of allergic asthma
por: McNicholl, Diarmuid M., et al.
Publicado: (2008)

Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
por: Kotoulas, Serafeim Chrysovalantis, et al.
Publicado: (2022)

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population
por: Licari, Amelia, et al.
Publicado: (2018)

To prevent the allergic disease: the dream of the allergist
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Asthma in children and adolescents: the ControL’Asma project
por: Licari, Amelia, et al.
Publicado: (2020)

Evaluation of safety and tolerability of a rush up-dosing allergen-specific immunotherapy with grass pollen, birch, hazel, and alder allergoid in children with allergic rhinoconjunctivitis, with or without asthma
por: Traina, Giovanni Maria, et al.
Publicado: (2021)

Anxiety in adolescents with severe asthma and response to treatment
por: Licari, Amelia, et al.
Publicado: (2020)

Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management
por: Poddighe, Dimitri, et al.
Publicado: (2016)

Complementary treatment of allergic rhinoconjunctivitis: the role of the nutraceutical Lertal®
por: Marseglia, Gianluigi, et al.
Publicado: (2020)

Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019
por: Ciprandi, Giorgio, et al.
Publicado: (2020)

Long-term benefits of omalizumab in a patient with severe non-allergic asthma
por: Menzella, Francesco, et al.
Publicado: (2011)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2012)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v99so5gntntrmibtrrjilfv7os